Zevra Therapeutics, Inc. financial data

Symbol
ZVRA on Nasdaq
Location
1180 Celebration Boulevard, Suite 103, Celebration, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 534 % +190%
Quick Ratio 6.04 %
Debt-to-equity 165 % -21.4%
Return On Equity 42.7 %
Return On Assets 16.1 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 56.3M shares +5.47%
Common Stock, Shares, Outstanding 56.2M shares +5.62%
Entity Public Float 205M USD +19%
Common Stock, Value, Issued 5K USD +25%
Weighted Average Number of Shares Outstanding, Basic 56M shares +17%
Weighted Average Number of Shares Outstanding, Diluted 56M shares +17%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 2.95M USD +1227%
Costs and Expenses 91.9M USD -6.8%
Operating Income (Loss) -87.7M USD -1.07%
Nonoperating Income (Expense) 141M USD +13.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 53.6M USD +97.1%
Income Tax Expense (Benefit) -433K USD
Net Income (Loss) Attributable to Parent 35.3M USD +98.4%
Earnings Per Share, Basic 0 USD/shares +98.6%
Earnings Per Share, Diluted -0.01 USD/shares +98.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 54.4M USD +0.74%
Cash, Cash Equivalents, and Short-term Investments 67.7M USD
Accounts Receivable, after Allowance for Credit Loss, Current 10.2M USD -36.9%
Inventory, Net 1.37M USD
Assets, Current 225M USD +126%
Other Long-term Investments 0 USD -100%
Property, Plant and Equipment, Net 488K USD -19.6%
Operating Lease, Right-of-Use Asset 1.34M USD +63%
Intangible Assets, Net (Excluding Goodwill) 6.74M USD -90.5%
Goodwill 4.7M USD 0%
Other Assets, Noncurrent 153K USD -70.1%
Assets 270M USD +41%
Accounts Payable, Current 13.1M USD -6.52%
Liabilities, Current 26.1M USD -24.3%
Accrued Income Taxes, Noncurrent 17.5M USD
Operating Lease, Liability, Noncurrent 966K USD +100%
Other Liabilities, Noncurrent 4M USD -27.6%
Liabilities 137M USD +12.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.42M USD -2001%
Retained Earnings (Accumulated Deficit) -434M USD +7.52%
Stockholders' Equity Attributable to Parent 133M USD +90.9%
Liabilities and Equity 270M USD +41%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.22M USD +49.1%
Net Cash Provided by (Used in) Financing Activities 1.61M USD +32%
Net Cash Provided by (Used in) Investing Activities 10.5M USD -28.7%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 57.8M shares +5.46%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.56M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.31M USD +833%
Deferred Tax Assets, Valuation Allowance 146M USD +8.83%
Deferred Tax Assets, Gross 163M USD +9.49%
Operating Lease, Liability 1.41M USD +37.5%
Payments to Acquire Property, Plant, and Equipment 99K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 33M USD +98.4%
Lessee, Operating Lease, Liability, to be Paid 1.7M USD +42.1%
Property, Plant and Equipment, Gross 2.08M USD -12.2%
Operating Lease, Liability, Current 441K USD -18.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 542K USD +271%
Lessee, Operating Lease, Liability, to be Paid, Year One 552K USD +2.99%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure +31.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 291K USD +69.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 393K USD +189%
Deferred Tax Assets, Operating Loss Carryforwards 101M USD +10.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 39K USD -75.8%
Operating Lease, Payments 215K USD +74.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 5.16M USD -4.25%
Depreciation, Depletion and Amortization 1.65M USD +5.57%
Share-based Payment Arrangement, Expense 12.4M USD -10.1%
Interest Expense 2.05M USD +301%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares